Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Sato

Showing results (151-160 of 487) with videos related to

Pageof 49
Sort By:
World Journal of Gastroenterology|March 15, 2006
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trialHideyuki Suzuki, Hitoshi Takagi, Naondo Sohara, et al.
Leukemia Research|September 6, 2005
Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosisKazuto Ogura, Fumihiko Kimura, Shinichi Kobayashi, et al.
Acta Medica Okayama|April 25, 2019
Clinical Characteristics of Severe Refractory Asthma Associated with the Effectiveness of Bronchial ThermoplastyDaisuke Minami, Hiroe Kayatani, Ken Sato, et al.
Japanese Journal of Radiology|April 25, 2019
Detectability of the choroid plexus of the third ventricle with magnetic resonance ventriculographyKen Sato, Masanori Awaji, Shoichi Inagawa, et al.
World Journal of Hepatology|December 22, 2010
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis CHideyuki Suzuki, Satoru Kakizaki, Norio Horiguchi, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2006
Pneumatosis cystoides intestinalis after alpha-glucosidase inhibitor treatment in a patient with interstitial pneumonitisAkiko Hisamoto, Takaaki Mizushima, Ken Sato, et al.
Oncology Reports|July 19, 2008
Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinomaKazuma Ohtaka, Naohiko Kohya, Ken Sato, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2006
Zinc is a negative regulator of hepatitis C virus RNA replicationKazuhisa Yuasa, Atsushi Naganuma, Ken Sato, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Interstrain differences in susceptibility to non-alcoholic steatohepatitisYuichi Yamazaki, Satoru Kakizaki, Daichi Takizawa, et al.
World Journal of Gastroenterology|September 17, 2013
Extended therapy duration for therapy-refractory hepatitis C patients with genotype 2Ken Sato, Masatoshi Yanagisawa, Hiroaki Hashizume, et al.
Pageof 49

Showing results (151-160 of 487) with videos related to

Sort By:
Pageof 49
World Journal of Gastroenterology|March 15, 2006
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trialHideyuki Suzuki, Hitoshi Takagi, Naondo Sohara, et al.
Leukemia Research|September 6, 2005
Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosisKazuto Ogura, Fumihiko Kimura, Shinichi Kobayashi, et al.
Acta Medica Okayama|April 25, 2019
Clinical Characteristics of Severe Refractory Asthma Associated with the Effectiveness of Bronchial ThermoplastyDaisuke Minami, Hiroe Kayatani, Ken Sato, et al.
Japanese Journal of Radiology|April 25, 2019
Detectability of the choroid plexus of the third ventricle with magnetic resonance ventriculographyKen Sato, Masanori Awaji, Shoichi Inagawa, et al.
World Journal of Hepatology|December 22, 2010
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis CHideyuki Suzuki, Satoru Kakizaki, Norio Horiguchi, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2006
Pneumatosis cystoides intestinalis after alpha-glucosidase inhibitor treatment in a patient with interstitial pneumonitisAkiko Hisamoto, Takaaki Mizushima, Ken Sato, et al.
Oncology Reports|July 19, 2008
Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinomaKazuma Ohtaka, Naohiko Kohya, Ken Sato, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2006
Zinc is a negative regulator of hepatitis C virus RNA replicationKazuhisa Yuasa, Atsushi Naganuma, Ken Sato, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Interstrain differences in susceptibility to non-alcoholic steatohepatitisYuichi Yamazaki, Satoru Kakizaki, Daichi Takizawa, et al.
World Journal of Gastroenterology|September 17, 2013
Extended therapy duration for therapy-refractory hepatitis C patients with genotype 2Ken Sato, Masatoshi Yanagisawa, Hiroaki Hashizume, et al.
Pageof 49